Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits.
Rossetti GG, Ossorio MA, Rempel S, Kratzel A, Dionellis VS, Barriot S, Tropia L, Gorgulla C, Arthanari H, Thiel V, Mohr P, Gamboni R, Halazonetis TD.
Rossetti GG, et al. Among authors: ossorio ma.
Sci Rep. 2022 Feb 15;12(1):2505. doi: 10.1038/s41598-022-06306-4.
Sci Rep. 2022.
PMID: 35169179
Free PMC article.